Hosted on MSN9mon
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptomsMore information: Rui Li et al, Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis, Science Immunology (2024). DOI: 10.1126/sciimmunol ...
A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...
Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 ...
Background: Multiple sclerosis is a chronic inflammatory disease of the central nervous system with a pronounced neurodegenerative component. It has been suggested that novel treatment options are ...
Linking yawning with fatigue, cortisol, and brain temperature, the hypothesis is ideally suited to being tested on people with multiple sclerosis (MS). Patients with the neurodegenerative disorder ...
Our division, working in conjunction with the UAB Multiple Sclerosis Center, fosters clinical, research and educational activities in the area of neuroimmunology with emphasis on multiple sclerosis.
ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less ...
Toronto, ON, January 22, 2025 – People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results